Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04535193 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Open-Label Study of 18F-mFBG for Imaging Myocardial Sympathetic Innervation

StatusActive, Not Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Completed to Active, Not Recruiting Completion date: Mar 7, 2025 to Aug 30, 2026v11 Show 1 more changeShow less
    • Completion date: Mar 7, 2025 to Aug 30, 2026
  2. Trial status: Recruiting to Completed Enrollment target: estimated 20 to confirmed 10 · Primary completion date changed from estimate of Mar 30, 2025 to Mar 7, 2025 · Study completion date changed from estimate of Sep 30, 2025 to Mar 7, 2025 · 1 morev10 Show 4 more changesShow less
    • Enrollment target: estimated 20 to confirmed 10
    • Primary completion date changed from estimate of Mar 30, 2025 to Mar 7, 2025
    • Study completion date changed from estimate of Sep 30, 2025 to Mar 7, 2025
    • Site details revised
  3. Collaborator revisedv9 See this version in full on ClinicalTrials.gov ↗
  4. Primary completion date: Sep 30, 2024 to Mar 30, 2025 Completion date: Dec 31, 2024 to Sep 30, 2025v8 Show 1 more changeShow less
    • Completion date: Dec 31, 2024 to Sep 30, 2025
  5. Primary completion date: Dec 31, 2023 to Sep 30, 2024 Completion date: Dec 31, 2023 to Dec 31, 2024v7 Show 1 more changeShow less
    • Completion date: Dec 31, 2023 to Dec 31, 2024
Show 5 earlier versionsHide 5 earlier versions
  1. Primary completion date: Sep 2022 to Dec 31, 2023 Completion date: Oct 2022 to Dec 31, 2023 · Site contact updatedv6 Show 2 more changesShow less
    • Completion date: Oct 2022 to Dec 31, 2023
    • Site contact updated
  2. Primary completion date: Apr 2022 to Sep 2022 Completion date: Jul 2022 to Oct 2022v5 Show 1 more changeShow less
    • Completion date: Jul 2022 to Oct 2022
  3. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Sep 2021 to Nov 5, 2021v4 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 2021 to Nov 5, 2021
  4. Primary completion date: Sep 30, 2021 to Apr 2022 Start date: Feb 7, 2021 to Sep 2021 · Completion date: Dec 30, 2021 to Jul 2022v3 Show 2 more changesShow less
    • Start date: Feb 7, 2021 to Sep 2021
    • Completion date: Dec 30, 2021 to Jul 2022
  5. Start date: Nov 1, 2020 to Feb 7, 2021 Primary completion date: Jun 30, 2021 to Sep 30, 2021 · Completion date: Oct 30, 2021 to Dec 30, 2021v2 Show 2 more changesShow less
    • Primary completion date: Jun 30, 2021 to Sep 30, 2021
    • Completion date: Oct 30, 2021 to Dec 30, 2021
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a Phase 1/2 study evaluating the positron-emitting radiopharmaceutical 18F-mFBG as an imaging agent for quantification of myocardial sympathetic innervation.
Trial Details
NCT Number NCT04535193
Lead Sponsor Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Collaborators: Mount Sinai Hospital, New York
Conditions Cardiovascular Diseases
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov